BioSante Pharmaceuticals

BioSante Pharmaceuticals, Inc. (BioSante) is a specialty pharmaceutical company focused on developing products for women's sexual health, menopause, contraception, and male hypogonadism. The company’s products for women's sexual health, menopause, contraception, and male hypogonadism include LibiGel, a once-daily transdermal testosterone gel under Special Protocol Assessment (SPA) for the treatment of Female Sexual Dysfunction (FSD) in Phase III clinical development; Elestrin, a once-daily transdermal estradiol (estrogen) gel for the treatment of moderate to severe vasomotor symptoms; and Pill-Plus (a triple-component contraceptive), a once-daily combination of estrogen, progestin, and androgen for the treatment of Female Sexual Dysfunction (FSD) in women using oral or transdermal contraceptives.